In vitro and in vivo Study of a Novel Liposome-Mediated Dual Drug Delivery for Synergistic Lung Cancer Therapy via Oral Administration
Qi Zhou, Zhiqiang Fu Department of Thoracic Surgery, Shanghai Shidong Hospital, Yangpu District, Shanghai 200438, People’s Republic of ChinaCorrespondence: Zhiqiang Fu Tel +86 21-25066666Email Fuzhiqiang1311@163.comBackground: To establish the co-delivery liposomes of gefitinib (GFT) and c...
Main Authors: | Zhou Q, Fu Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/in-vitro-and-in-vivo-study-of-a-novel-liposome-mediated-dual-drug-deli-peer-reviewed-article-OTT |
Similar Items
-
Composition Influence on Pulmonary Delivery of Rifampicin Liposomes
by: Maria Letizia Manca, et al.
Published: (2012-11-01) -
Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform
by: Li X, et al.
Published: (2016-12-01) -
Formulation of a therapeutic cationic liposome-siRNA complex for development to fight osteosarcoma
by: Bibi Fatemeh Haghiralsadat, et al.
Published: (2018-04-01) -
Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
by: Liu HM, et al.
Published: (2017-02-01) -
RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy
by: Long Q, et al.
Published: (2020-12-01)